Quick Answer
Genenta Science S.p.A. reported Net Income of -$8.91 million for fiscal year 2024.
Genenta Science S.p.A. — Key Financials by Year
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Net Income | -$8.91M +23.5% |
-$11.65M -37.4% |
-$8.48M -53.3% |
-$5.53M +1.1% |
-$5.59M -21.6% |
-$4.60M |
| Diluted EPS | -$0.49 +23.4% |
-$0.64 -36.2% |
-$0.47 -27.0% |
-$0.37 | — | — |
| Total Assets | $14.82M -33.7% |
$22.35M -33.2% |
$33.44M -16.5% |
$40.03M +128.7% |
$17.50M | — |
| Cash and Equivalents | $4.58M +24.1% |
$3.69M -87.6% |
$29.79M -20.0% |
$37.24M +140.8% |
$15.47M | — |
| Stockholders Equity | $12.50M -38.8% |
$20.43M -34.4% |
$31.14M -19.9% |
$38.86M +156.5% |
$15.15M -19.6% |
$18.85M +137.7% |
| R&D Expense | $4.81M -25.7% |
$6.47M +3997.7% |
$158.0K -95.3% |
$3.39M -27.7% |
$4.69M +26.6% |
$3.70M |
| Operating Income | -$9.76M +16.8% |
-$11.73M -6.2% |
-$11.04M -94.2% |
-$5.69M -1.7% |
-$5.59M -20.9% |
-$4.62M |
| Shares Outstanding | 18.29M +0.4% |
18.22M +0.0% |
18.22M +0.0% |
18.22M +0.0% |
18.22M | — |
- Genenta Science S.p.A. reported Net Income of -$8.91 million for fiscal year 2024.
- Genenta Science S.p.A. showed an increase of +23.5% in Net Income compared to the prior fiscal year.
- Genenta Science S.p.A. reported Diluted EPS of $0.49 per share (loss) for fiscal year 2024.
- Genenta Science S.p.A. showed an increase of +23.4% in Diluted EPS compared to the prior fiscal year.
- Genenta Science S.p.A. reported Total Assets of $14.82 million for fiscal year 2024.
- Genenta Science S.p.A. showed a decrease of -33.7% in Total Assets compared to the prior fiscal year.
- Genenta Science S.p.A. reported Cash and Equivalents of $4.58 million for fiscal year 2024.
- Genenta Science S.p.A. showed an increase of +24.1% in Cash and Equivalents compared to the prior fiscal year.
- Genenta Science S.p.A. reported Stockholders Equity of $12.50 million for fiscal year 2024.
- Genenta Science S.p.A. showed a decrease of -38.8% in Stockholders Equity compared to the prior fiscal year.
- Genenta Science S.p.A. reported R&D Expense of $4.81 million for fiscal year 2024.
- Genenta Science S.p.A. showed a decrease of -25.7% in R&D Expense compared to the prior fiscal year.
- Genenta Science S.p.A. reported Operating Income of -$9.76 million for fiscal year 2024.
- Genenta Science S.p.A. showed an increase of +16.8% in Operating Income compared to the prior fiscal year.
- Genenta Science S.p.A. reported Shares Outstanding of 18.29 million shares for fiscal year 2024.
- Genenta Science S.p.A. showed an increase of +0.4% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: